Concourse Financial Group Securities, Inc. Crispr Therapeutics Ag Transaction History

Concourse Financial Group Securities, Inc.

  • $1.67 Billion
  • Q4 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 200 shares of CRSP stock, worth $8,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$8,784
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$44.62 - $62.75 $3,078 - $4,329
-69 Reduced 25.65%
200 $9,000
Q2 2024

Jul 23, 2024
BUY
$51.17 - $68.18 $3,377 - $4,499
66 Added 32.51%
269 $14,000
Q1 2024

Apr 30, 2024
BUY
$60.67 - $89.12 $60 - $89
1 Added 0.5%
203 $13,000
Q3 2023

Oct 25, 2023
BUY
$45.39 - $59.0 $90 - $118
2 Added 1.0%
202 $9,000
Q4 2022

Jan 30, 2023
BUY
$39.19 - $65.67 $7,838 - $13,134
200 New
200 $0
Q3 2022

Nov 15, 2022
SELL
$61.1 - $83.78 $12,220 - $16,756
-200 Closed
0 $0
Q1 2022

May 09, 2022
SELL
$53.19 - $79.24 $11,967 - $17,829
-225 Reduced 52.94%
200 $13,000
Q4 2021

Feb 07, 2022
SELL
$70.09 - $111.29 $5,326 - $8,458
-76 Reduced 15.17%
425 $32,000
Q3 2021

Nov 09, 2021
SELL
$110.2 - $156.64 $4,297 - $6,108
-39 Reduced 7.22%
501 $56,000
Q2 2021

Aug 13, 2021
BUY
$100.84 - $161.89 $6,252 - $10,037
62 Added 12.97%
540 $87,000
Q1 2021

May 13, 2021
BUY
$110.72 - $210.04 $25,687 - $48,729
232 Added 94.31%
478 $58,000
Q4 2020

Feb 02, 2021
BUY
$79.67 - $173.23 $5,019 - $10,913
63 Added 34.43%
246 $38,000
Q3 2020

Nov 13, 2020
SELL
$78.5 - $100.64 $4,474 - $5,736
-57 Reduced 23.75%
183 $15,000
Q2 2020

Aug 13, 2020
BUY
$38.5 - $76.05 $5,390 - $10,647
140 Added 140.0%
240 $18,000
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $3,668 - $7,313
100 New
100 $6,000
Q3 2019

Nov 13, 2019
BUY
$40.99 - $52.56 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$35.45 - $48.2 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$28.02 - $40.87 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$22.73 - $42.34 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$44.35 - $65.71 $0 - $0
0 New
0 $0

Others Institutions Holding CRSP

# of Institutions
486
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.43B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email